Agenus Announces Up to $340M Financing to Advance Phase 3 ROBBIN of Neoadjuvant BOT/BAL in MSS Colon Cancer
Jul 13, 2026
View online
Agenus Announces Up to $340M Financing to Advance Phase 3 ROBBIN of Neoadjuvant BOT/BAL in MSS Colon Cancer
2026 IBRI Global Forum on Science, Philanthropy, and Investment
NCCN Breast Cancer Version 4.2026: Metastatic Treatment Moves Further Toward Biomarker-Driven Sequencing
10 Must-Read Posts In GU Oncology This Week
Laura Towart : How Much Younger Can You Get in Six Months?
WHO Global Cancer Report 2026: GI Cancers Show the Cost of Delayed Prevention, Diagnosis, and Access
Nara Smith Opens Up About Her Two-Year-Old Daughter’s Cancer Battle
The Future of Oncology is Ensuring the Discoveries Reach Every Patient – CancerWorld
Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA
ACOG Foundation 2026 Request for Grant Proposals
HER2 and Colorectal Cancer: What Advocates Need to Know
Breast Cancer Trials 47th Annual Scientific Meeting
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
